Midkine confers Adriamycin resistance in human gastric cancer cells

被引:20
作者
Xu, Ying-ying [1 ]
Mao, Xiao-yun [1 ]
Song, Yong-xi [2 ]
Zhao, Feng [2 ]
Wang, Zhen-ning [2 ]
Zhang, Wei-xu [3 ]
Xu, Hui-mian [2 ]
Jin, Feng [1 ]
机构
[1] China Med Univ, Affiliated Hosp 1, Res Unit Gen Surg, Dept Breast Surg,Dept Surg Oncol, Shenyang 110001, Liaoning Provin, Peoples R China
[2] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang 110001, Liaoning Provin, Peoples R China
[3] China Med Univ, Shenyang 110001, Liaoning Provin, Peoples R China
基金
美国国家科学基金会;
关键词
Midkine; Adriamycin resistance; Gastric cancer; GROWTH-FACTOR; DRUG-RESISTANCE; BREAST-CANCER; CARCINOMA; AKT; PLEIOTROPHIN; INVOLVEMENT; BIOMARKER; SURVIVAL; KINASE;
D O I
10.1007/s13277-012-0406-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Midkine (MDK) is a heparin-binding molecule involved in the regulation of growth and differentiation during embryogenesis, which is overexpressed in most of human malignant tumors and may act as an oncoprotein. The aim of the current study was to investigate the mechanism of MDK involved in the Adriamycin (ADR) resistance in human gastric cancer cells in vitro. We found that Adriamycin-resistant SGC7901 (SGC7901/ADR) exhibited 58.6-fold greater resistance to ADR compared with Adriamycin-sensitive SGC7901 cell line. MDK mRNA and protein expression levels were significantly higher in SGC7901/ADR than in SGC7901. To gain a deeper insight into the role of MDK in SGC7901/ADR, we stably transfected Adriamycin-sensitive SGC7901 with viral vector expressing MDK. Our result showed that multidrug resistance type I (MDR1) was found in SGC7901/ADR, not in SGC7901 by RT-PCR regardless of MDK transfection. P-Glycoprotein, which is the MDR1-coded protein, was found in SGC7901/ADR, not in SGC7901 by Western blot regardless of MDK transfection. We investigated whether an activation of the tyrosine kinase pathway would change the drug resistance phenotype with MDK transfection. Western blot results showed the upregulation of phosphorylated protein kinase B (AKT) and phosphorylated extracellular signal-regulated protein kinase (ERK) in Adriamycin-sensitive SGC7901 cell by MDK transfection accompanied with drug resistance to ADR, although the level of AKT and ERK protein expression did not change, so our results suggested that MDK, which can activate AKT and ERK by phosphorylation, induced the Adriamycin resistance in gastric cancer cells. Understanding the molecular mechanisms, driving MDK-induced ADR resistance, will provide benefits in developing new therapies for gastric cancer.
引用
收藏
页码:1543 / 1548
页数:6
相关论文
共 21 条
[1]   RETRACTED: Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model (Retracted article. See vol. 40, pg. 1502, 2019) [J].
Dai, Li-cheng ;
Wang, Xiang ;
Yao, Xing ;
Min, Li-shan ;
Ping, Jin-liang ;
He, Jian-fang .
ACTA PHARMACOLOGICA SINICA, 2007, 28 (03) :453-458
[2]   In vitro and in vivo suppression of hepatocellular carcinoma growth by midkine-antisense oligonucleotide-loaded nanoparticles [J].
Dai, Li-Cheng ;
Yao, Xing ;
Wang, Xiang ;
Niu, Shu-Qiong ;
Zhou, Lin-Fu ;
Fu, Fang-Fang ;
Yang, Shui-Xin ;
Ping, Jin-Liang .
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (16) :1966-1972
[3]   Versican G3 Domain Modulates Breast Cancer Cell Apoptosis: A Mechanism for Breast Cancer Cell Response to Chemotherapy and EGFR Therapy [J].
Du, William Weidong ;
Yang, Burton B. ;
Yang, Bing L. ;
Deng, Zhaoqun ;
Fang, Ling ;
Shan, Sze Wan ;
Jeyapalan, Zina ;
Zhang, Yaou ;
Seth, Arun ;
Yee, Albert J. .
PLOS ONE, 2011, 6 (11)
[4]   Deciphering cellular states of innate tumor drug responses [J].
Graudens, E ;
Boulanger, V ;
Mollard, C ;
Mariage-Samson, R ;
Barlet, X ;
Grémy, G ;
Couillault, C ;
Lajémi, M ;
Piatier-Tonneau, D ;
Zaborski, P ;
Eveno, E ;
Auffray, C ;
Imbeaud, S .
GENOME BIOLOGY, 2006, 7 (03)
[5]   Enhanced Antitumorigenic Effects in Glioblastoma on Double Targeting of Pleiotrophin and Its Receptor ALK [J].
Grzelinski, Marius ;
Steinberg, Florian ;
Martens, Tobias ;
Czubayko, Frank ;
Lamszus, Katrin ;
Aigner, Achim .
NEOPLASIA, 2009, 11 (02) :145-156
[6]   The Angiogenic Growth Factor and Biomarker Midkine Is a Tumor-Shared Antigen [J].
Kerzerho, Jerome ;
Adotevi, Olivier ;
Castelli, Florence A. ;
Dosset, Magalie ;
Bernardeau, Karine ;
Szely, Natacha ;
Lang, Francois ;
Tartour, Eric ;
Maillere, Bernard .
JOURNAL OF IMMUNOLOGY, 2010, 185 (01) :418-423
[7]   Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance [J].
McCubrey, James A. ;
Steelman, Linda S. ;
Chappell, William H. ;
Abrams, Stephen L. ;
Wong, Ellis W. T. ;
Chang, Fumin ;
Lehmann, Brian ;
Terrian, David M. ;
Milella, Michele ;
Tafuri, Agostino ;
Stivala, Franca ;
Libra, Massimo ;
Basecke, Jorg ;
Evangelisti, Camilla ;
Martelli, Alberto M. ;
Franklin, Richard A. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2007, 1773 (08) :1263-1284
[8]   Midkine and pleiotrophin: Two related proteins involved in development, survival, inflammation and tumorigenesis [J].
Muramatsu, T .
JOURNAL OF BIOCHEMISTRY, 2002, 132 (03) :359-371
[9]   Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases [J].
Muramatsu, Takashi .
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2010, 86 (04) :410-425
[10]   AKT phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer [J].
Oki, E ;
Baba, H ;
Tokunaga, E ;
Nakamura, T ;
Ueda, N ;
Futatsugi, M ;
Mashino, K ;
Yamamoto, M ;
Ikebe, M ;
Kakeji, Y ;
Maehara, Y .
INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (03) :376-380